Clinical Lab Manager - News, Editorial and Products for the Clinical Laboratory

Melanoma

Sensitizing 'Cold' Melanomas to Immunotherapies

American Association for Cancer Research | May 06, 2020
Approximately 40 percent of melanomas lack sufficient infiltration of immune cells within the tumor and therefore have poor responses to immunotherapies